| NO | Nitric oxide |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| EDRF | Endothelial derived vasorelaxant factor |
| ECs | Endocannabinoid system |
| eNOS | Endothelial nitric oxide synthase |
| nNOS | Neuronal nitric oxide synthase |
| iNOS | Inducible nitric oxide synthase |
| cGMP | Cyclic 3′,5′-guanosine monophosphate |
| GC | Guanylate cyclase |
| l-NMMA | NG-monomethyl-l-arginine |
| l-NAME | Nw-nitro-l-arginine methyl ester |
| sGC | Soluble guanylyl cyclase |
| PDE | phosphodiesterase |
| SHR | Spontaneously hypertensive rats |
| LVH | Left ventricular hypertrophy |
| TAC | Transverse aortic constriction |
| ADMA | NG,NG-dimethylarginine |
| PCT | Proximal convoluted tubules |
| LPS | Lipopolysaccharide |
| H2S | Hydrogen sulfide |
| BH4 | Tetrahydrobiopterin |
| NE | Norepinephrine |
| NA | Noradrenaline |
| SNP | Sodium nitroprusside |
| AEA | Arachidonoyl ethanolamine (Anandamide) |
| 2-AG | 2-arachidonoylglycerol |
| FAAH | Fatty acid amide hydrolase |
| MAGL | Monoacylglycerol lipase |
| CB1 | Cannabinoid receptor type 1 |
| CB2 | Cannabinoid receptor type 2 |
| DAG | Diacylglycerol lipase |
| THC | Tetrahydrocannabinol |